213 related articles for article (PubMed ID: 23534885)
1. Desmopressin (DDAVP) improves recruitment of activated platelets to collagen but simultaneously increases platelet endothelial interactions in vitro.
Calmer S; Ferkau A; Larmann J; Johanning K; Czaja E; Hagl C; Echtermeyer F; Goudeva L; Heuft HG; Theilmeier G
Platelets; 2014; 25(1):8-15. PubMed ID: 23534885
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of 1-desamino-8-D-arginine vasopressin on direct adhesion of platelets to collagen.
Ghosh S; Rao AK
Thromb Res; 1993 Jun; 70(5):417-22. PubMed ID: 7690994
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo effects of desmopressin on platelet function.
Balduini CL; Noris P; Belletti S; Spedini P; Gamba G
Haematologica; 1999 Oct; 84(10):891-6. PubMed ID: 10509036
[TBL] [Abstract][Full Text] [Related]
4. Desmopressin (DDAVP) enhances platelet adhesion to the extracellular matrix of cultured human endothelial cells through increased expression of tissue factor.
Gálvez A; Gómez-Ortiz G; Díaz-Ricart M; Escolar G; González-Sarmiento R; Zurbano MJ; Ordinas A; Castillo R
Thromb Haemost; 1997 May; 77(5):975-80. PubMed ID: 9184413
[TBL] [Abstract][Full Text] [Related]
5. Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.
Escolar G; Cases A; Monteagudo J; Garrido M; Lopez J; Ordinas A; Revert L; Castillo R
J Lab Clin Med; 1989 Jul; 114(1):36-42. PubMed ID: 2738447
[TBL] [Abstract][Full Text] [Related]
6. Pre-treatment of porcine pulmonary xenograft with desmopressin: a novel strategy to attenuate platelet activation and systemic intravascular coagulation in an ex-vivo model of swine-to-human pulmonary xenotransplantation.
Kim YT; Lee HJ; Lee SW; Kim JY; Wi HC; Park SJ; Bae SJ; Kang HJ
Xenotransplantation; 2008 Feb; 15(1):27-35. PubMed ID: 18333911
[TBL] [Abstract][Full Text] [Related]
7. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
van Vliet HH; Kappers-Klunne MC; Leebeek FW; Michiels JJ
Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
[TBL] [Abstract][Full Text] [Related]
8. Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction.
Rose SS; Faiz A; Miller CH; Saidi P; Philipp CS
Haemophilia; 2008 May; 14(3):571-8. PubMed ID: 18312366
[TBL] [Abstract][Full Text] [Related]
9. Platelet adhesion to multimerin 1 in vitro: influences of platelet membrane receptors, von Willebrand factor and shear.
Tasneem S; Adam F; Minullina I; Pawlikowska M; Hui SK; Zheng S; Miller JL; Hayward CP
J Thromb Haemost; 2009 Apr; 7(4):685-92. PubMed ID: 19175495
[TBL] [Abstract][Full Text] [Related]
10. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Na+/H+ exchanger in desmopressin-induced platelet procoagulant response.
Tomasiak MM; Stelmach H; Bodzenta-Łukaszyk A; Tomasiak M
Acta Biochim Pol; 2004; 51(3):773-88. PubMed ID: 15448738
[TBL] [Abstract][Full Text] [Related]
12. Increased amounts of von Willebrand factor are bound to microparticles after infusion of desmopressin.
Trummer A; Haarmeijer B; Werwitzke S; Wermes C; Ganser A; Budde U; Tiede A
Haemophilia; 2013 Mar; 19(2):236-41. PubMed ID: 23051555
[TBL] [Abstract][Full Text] [Related]
13. [Shortening of acetylsalicylic acid-prolonged bleeding time by means of desmopressin].
Beck KH; Bleckmann U; Mohr P; Kretschmer V; Huss B
Beitr Infusionsther Transfusionsmed; 1994; 32():437-9. PubMed ID: 9480140
[TBL] [Abstract][Full Text] [Related]
14. Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation.
Casonato A; Steffan A; Pontara E; Zucchetto A; Rossi C; De Marco L; Girolami A
Thromb Haemost; 1999 Feb; 81(2):224-8. PubMed ID: 10063996
[TBL] [Abstract][Full Text] [Related]
15. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of desmopressin effect on primary haemostasis in pediatric patients with aspirin-like defect as hereditary thrombocytopathy.
Tauer JT; Gneuss A; Lohse JE; Jürgens T; Knöfler R
Klin Padiatr; 2011 May; 223(3):169-72. PubMed ID: 21509710
[TBL] [Abstract][Full Text] [Related]
17. The von Willebrand factor antagonist (GPG-290) prevents coronary thrombosis without prolongation of bleeding time.
Wadanoli M; Sako D; Shaw GD; Schaub RG; Wang Q; Tchernychev B; Xu J; Porter TJ; Huang Q
Thromb Haemost; 2007 Aug; 98(2):397-405. PubMed ID: 17721623
[TBL] [Abstract][Full Text] [Related]
18. [Utility of desmopressin in 4 cases of thrombocytopathies associated with giant platelets].
Martínez-Murillo C; Quintana-González S; Ambriz-Fernández R; Arzate-Hernández G; Gutiérrez-Romero M; Gaminio-Gómez E
Rev Invest Clin; 1997; 49(4):281-6. PubMed ID: 9707993
[TBL] [Abstract][Full Text] [Related]
19. The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects.
Colucci G; Stutz M; Rochat S; Conte T; Pavicic M; Reusser M; Giabbani E; Huynh A; Thürlemann C; Keller P; Alberio L
Blood; 2014 Mar; 123(12):1905-16. PubMed ID: 24443440
[TBL] [Abstract][Full Text] [Related]
20. Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis.
Kanaji S; Fahs SA; Shi Q; Haberichter SL; Montgomery RR
J Thromb Haemost; 2012 Aug; 10(8):1646-52. PubMed ID: 22642380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]